Biofrontera Ownership 2024 | Who Owns Biofrontera Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

0.74%

Insider Ownership

25.97%

Retail Ownership

73.29%

Institutional Holders

1.00

Biofrontera Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CARY STREET PARTNERS INVESTMENT ADVISORY LLC	-	-	-	-25	-100.00%	-	Dec 31, 2023

Biofrontera's largest institutional shareholder is CARY STREET PARTNERS INVESTMENT ADVISORY LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CARY STREET PARTNERS INVESTMENT ADVISORY LLC	-	-	-	-25	-100.00%	-	Dec 31, 2023

The largest Biofrontera shareholder by % of total assets is CARY STREET PARTNERS INVESTMENT ADVISORY LLC. The company owns 0.00 shares of Biofrontera (BFRI), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CARY STREET PARTNERS INVESTMENT ADVISORY LLC	-	-	-	-25	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, Biofrontera's largest institutional buyer is CARY STREET PARTNERS INVESTMENT ADVISORY LLC. The company purchased -25.00 stocks of BFRI, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CARY STREET PARTNERS INVESTMENT ADVISORY LLC	-	-	-	-25	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, Biofrontera's biggest institutional seller is CARY STREET PARTNERS INVESTMENT ADVISORY LLC. The company sold -25.00 shares of BFRI, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CARY STREET PARTNERS INVESTMENT ADVISORY LLC	-	-	-	-25	-100.00%	-	Dec 31, 2023

Biofrontera's largest sold out institutional shareholder by shares sold is CARY STREET PARTNERS INVESTMENT ADVISORY LLC, sold -25.00 shares, valued at -, as of undefined.

Biofrontera Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	219,052	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	77,365	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	6,207	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	8,611	-8,611	-50.00%	Mar 31, 2024
iSHARES TRUST	0.00%	37,929	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,441	-	-	Mar 31, 2024

Biofrontera's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 219.05K shares, compromising 0.00% of its total assets.

Biofrontera Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 23	1	-90.91%
30 Jun, 23	11	-26.67%
31 Mar, 23	15	7.14%
31 Dec, 22	14	7.69%
30 Sep, 22	13	-
30 Jun, 22	13	18.18%
31 Mar, 22	11	-
31 Dec, 21	11	-

As of 30 Sep 23, 1 institutions are holding Biofrontera's shares, representing a decrease of -90.91% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 23	25	-100.00%
30 Jun, 23	794,002	-6.49%
31 Mar, 23	849,115	6.73%
31 Dec, 22	795,570	-6.79%
30 Sep, 22	853,550	-46.99%
30 Jun, 22	1,610,068	101.64%
31 Mar, 22	798,484	14.00%
31 Dec, 21	700,453	-

Biofrontera (BFRI) has 25.00 shares outstanding as of 30 Sep 23, down -100.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 23	0.74%	3324.48%
30 Jun, 23	0.15%	1.47%
31 Mar, 23	3.18%	35.82%
31 Dec, 22	2.98%	21.12%
30 Sep, 22	3.76%	5.13%
30 Jun, 22	8.55%	39.25%
31 Mar, 22	4.67%	11.51%
31 Dec, 21	6.37%	-

As of 30 Sep 23, Biofrontera is held by 0.74% institutional shareholders, representing a 3324.48% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 23	1	-50.00%
30 Jun, 23	2	-75.00%
31 Mar, 23	8	-
31 Dec, 22	8	33.33%
30 Sep, 22	6	-40.00%
30 Jun, 22	10	25.00%
31 Mar, 22	8	-27.27%
31 Dec, 21	11	-

1 institutional shareholders have increased their position in BFRI stock as of 30 Sep 23 compared to 2 in the previous quarter (a -50.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 23	-	-100.00%
30 Jun, 23	5	400.00%
31 Mar, 23	1	-66.67%
31 Dec, 22	3	-
30 Sep, 22	3	-
30 Jun, 22	3	50.00%
31 Mar, 22	2	-
31 Dec, 21	-	-

- institutional shareholders have reduced their position in BFRI stock as of 30 Sep 23 compared to 5 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 23	1	-90.91%	25	-100.00%	0.74%	3324.48%	1	-50.00%	-	-100.00%
30 Jun, 23	11	-26.67%	794,002	-6.49%	0.15%	1.47%	2	-75.00%	5	400.00%
31 Mar, 23	15	7.14%	849,115	6.73%	3.18%	35.82%	8	-	1	-66.67%
31 Dec, 22	14	7.69%	795,570	-6.79%	2.98%	21.12%	8	33.33%	3	-
30 Sep, 22	13	-	853,550	-46.99%	3.76%	5.13%	6	-40.00%	3	-
30 Jun, 22	13	18.18%	1,610,068	101.64%	8.55%	39.25%	10	25.00%	3	50.00%
31 Mar, 22	11	-	798,484	14.00%	4.67%	11.51%	8	-27.27%	2	-
31 Dec, 21	11	-	700,453	-	6.37%	-	11	-	-	-

Biofrontera Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 22, 2024	Luebbert Hermann	director, officer	CEO & Exec. Chairman	M-Exempt	Sell	4,771	-	-	-
May 22, 2023	Monaco Erica L.	officer	Chief Executive Officer	M-Exempt	Sell	76,336	-	-	76,336
May 22, 2023	Luebbert Hermann	director, officer	Executive Chairman	M-Exempt	Sell	95,420	-	-	95,420

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 16, 2024	Weber Kevin Daniel	director	-	A-Award	Buy	20,000	$1.38	$27.60K	21,100
Jul 16, 2024	Lanckriet Heikki	director	-	A-Award	Buy	20,000	$1.38	$27.60K	20,000
Jul 16, 2024	Leffler Eugene Frederick	officer	Chief Financial Officer	A-Award	Buy	175,000	$1.38	$241.50K	180,000
Jul 16, 2024	Leffler Eugene Frederick	officer	Chief Financial Officer	A-Award	Buy	175,000	-	-	175,000
Jul 16, 2024	Hoffman Beth J.	director	-	A-Award	Buy	20,000	$1.38	$27.60K	21,100
Jul 16, 2024	Luebbert Hermann	director, officer	CEO & Chairman	A-Award	Buy	275,000	$1.38	$379.50K	290,211
Jul 16, 2024	Luebbert Hermann	director, officer	CEO & Chairman	A-Award	Buy	275,000	-	-	275,000
Jul 16, 2024	BORER JOHN J III	director	-	A-Award	Buy	20,000	$1.38	$27.60K	21,100
May 22, 2024	Luebbert Hermann	director, officer	CEO & Exec. Chairman	M-Exempt	Buy	4,771	-	-	15,211
May 22, 2024	Luebbert Hermann	director, officer	CEO & Exec. Chairman	M-Exempt	Sell	4,771	-	-	-
Aug 22, 2023	Lanckriet Heikki	director			Buy	-	-	-	-
May 22, 2023	Monaco Erica L.	officer	Chief Executive Officer	M-Exempt	Buy	76,336	-	-	133,025
May 22, 2023	Monaco Erica L.	officer	Chief Executive Officer	M-Exempt	Sell	76,336	-	-	76,336
May 22, 2023	Luebbert Hermann	director, officer	Executive Chairman	M-Exempt	Buy	95,420	-	-	208,799
May 22, 2023	Luebbert Hermann	director, officer	Executive Chairman	M-Exempt	Sell	95,420	-	-	95,420
Jan 12, 2023	Leffler Eugene Frederick	officer	Chief Financial Officer	A-Award	Buy	100,000	-	-	100,000
Jan 12, 2023	Gates Erica F.	officer	-		Buy	-	-	-	-
Nov 04, 2022	Leffler Eugene Frederick	-	-		Buy	-	-	-	-
Nov 04, 2022	Leffler Eugene Frederick	officer	-		Buy	-	-	-	-
Jun 06, 2022	Wedge Loretta M.	director	-	A-Award	Buy	22,000	$2.61	$57.42K	22,000

The last insider sell of Biofrontera's stock was made by Luebbert Hermann on May 22 2024, selling 4,771 shares at - per share (valued at -).

Biofrontera Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	1	-	-
Q4 2022	-	-	-
Q2 2022	11	-	-
Q1 2022	-	-	-
Q4 2021	7	1	700.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Biofrontera's insiders, as of Q1 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	-	-
Q4 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-

As of Q1 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Biofrontera's stocks.

Biofrontera Peer Ownership

Ticker	Company
AKAN	Akanda Corp.
EVOK	Evoke Pharma, Inc.
ACOR	Acorda Therapeutics, Inc.
GHSI	Guardion Health Sciences, Inc.
RGC	Regencell Bioscience Holdings Limited
IXHL	Incannex Healthcare Limited
SHPH	Shuttle Pharmaceuticals Holdings, Inc.
PTPI	Petros Pharmaceuticals, Inc.
HUGE	FSD Pharma Inc.
CPIX	Cumberland Pharmaceuticals Inc.
PROC	Procaps Group S.A.
JUPW	Safety Shot Inc
LSDI	Lucy Scientific Discovery Inc.
PRFX	PainReform Ltd.
AGRX	Agile Therapeutics, Inc.
SXTC	China SXT Pharmaceuticals, Inc.
EGRX	Eagle Pharmaceuticals, Inc.

BFRI Ownership FAQ

Who Owns Biofrontera?

Biofrontera is owned by institutional shareholders (0.74%), insiders (25.97%), and public (73.29%). The largest institutional shareholder of Biofrontera is CARY STREET PARTNERS INVESTMENT ADVISORY LLC (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Biofrontera?

Biofrontera's major institutional shareholders are CARY STREET PARTNERS INVESTMENT ADVISORY LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Biofrontera shareholders are there?

As of Sep 2023, there are 1 institutional shareholders of Biofrontera.

What percentage of Biofrontera is owned by CARY STREET PARTNERS INVESTMENT ADVISORY LLC?

CARY STREET PARTNERS INVESTMENT ADVISORY LLC owns 0 shares of Biofrontera, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).